X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3325) 3325
Book Review (621) 621
Publication (592) 592
Book Chapter (27) 27
Conference Proceeding (16) 16
Dissertation (7) 7
Book / eBook (4) 4
Government Document (3) 3
Magazine Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3104) 3104
humans (2096) 2096
animals (2044) 2044
sphingosine - analogs & derivatives (1601) 1601
lysophospholipids - metabolism (1205) 1205
mice (937) 937
sphingosine 1-phosphate (833) 833
sphingosine - metabolism (828) 828
lysophospholipids - pharmacology (795) 795
biochemistry & molecular biology (781) 781
lipids (766) 766
male (743) 743
lysophosphatidic acid (731) 731
sphingosine-1-phosphate (708) 708
cell biology (683) 683
female (671) 671
signal transduction (569) 569
sphingosine (559) 559
lysophospholipids (550) 550
cells, cultured (522) 522
sphingosine - pharmacology (502) 502
rats (478) 478
phosphates (438) 438
lysophospholipids - blood (406) 406
activation (403) 403
cells (378) 378
article (359) 359
receptors, lysosphingolipid - metabolism (348) 348
expression (346) 346
apoptosis (329) 329
mice, inbred c57bl (322) 322
protein-coupled receptor (313) 313
physiological aspects (303) 303
inflammation (295) 295
lysophospholipids - physiology (270) 270
research (269) 269
signal transduction - drug effects (264) 264
analysis (262) 262
pharmacology & pharmacy (257) 257
immunology (251) 251
endothelial-cells (246) 246
physiology (246) 246
proteins (244) 244
receptor (244) 244
cancer (243) 243
oncology (233) 233
phosphorylation (230) 230
mice, knockout (224) 224
cell line (223) 223
receptors (218) 218
in-vivo (217) 217
phosphotransferases - metabolism (217) 217
middle aged (216) 216
sphingosine - blood (212) 212
adult (208) 208
hematology (203) 203
abridged index medicus (202) 202
cell line, tumor (202) 202
phospholipids (200) 200
biophysics (197) 197
angiogenesis (196) 196
sphingosine - physiology (196) 196
kinases (191) 191
receptors, lysophosphatidic acid - metabolism (186) 186
dose-response relationship, drug (185) 185
signal transduction - physiology (185) 185
migration (182) 182
multidisciplinary sciences (182) 182
sphingosine kinase (180) 180
sphingolipids (179) 179
metabolism (178) 178
time factors (178) 178
identification (171) 171
autotaxin (167) 167
neurosciences (166) 166
rodents (166) 166
research article (165) 165
fty720 (164) 164
disease models, animal (163) 163
gene expression (162) 162
mass spectrometry (160) 160
calcium - metabolism (158) 158
lysophospholipids - chemistry (158) 158
proliferation (155) 155
cell movement - drug effects (152) 152
enzymes (152) 152
receptors, lysosphingolipid - genetics (152) 152
s1p (150) 150
lymphocyte egress (149) 149
peripheral vascular disease (149) 149
protein-coupled receptors (148) 148
aged (145) 145
lpa (145) 145
medicine, research & experimental (143) 143
plasma (142) 142
atherosclerosis (141) 141
growth-factor (141) 141
rats, sprague-dawley (140) 140
cell movement (139) 139
enzyme inhibitors - pharmacology (139) 139
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3278) 3278
Japanese (20) 20
Chinese (15) 15
Russian (13) 13
French (7) 7
German (2) 2
Italian (2) 2
Polish (2) 2
Czech (1) 1
Hungarian (1) 1
Korean (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BBA - Molecular and Cell Biology of Lipids, ISSN 1388-1981, 10/2008, Volume 1781, Issue 10, pp. 655 - 664
Circulating blood cell lipid composition may become increasingly important to provide new insights into cellular lipid abnormalities in diseases. Here we... 
Monocytes | Granulocytes | Lymphocytes | Red blood cell | Phospholipid | Lipidomics | ESI-MS/MS | Platelets | HUMAN-PLATELETS | FATTY-ACID-COMPOSITION | BIOCHEMISTRY & MOLECULAR BIOLOGY | MONONUCLEAR-CELLS | PHOSPHOLIPIDS | QUANTITATIVE-ANALYSIS | CELL BIOLOGY | PLASMA | BIOPHYSICS | ERYTHROCYTES | HIGH-THROUGHPUT QUANTIFICATION | HUMAN-LIVER DISEASE | Phosphatidylinositols - analysis | Cholesterol - blood | Humans | Phospholipid Ethers - analysis | Ceramides - blood | Male | Erythrocytes - chemistry | Cholesterol Esters - blood | Lipids - chemistry | Lysophospholipids - analysis | Phosphatidylinositols - blood | Plasmalogens - blood | Lipids - blood | Cholesterol - analysis | Adult | Female | Phospholipid Ethers - blood | Fatty Acids - blood | Lysophosphatidylcholines - blood | Lymphocytes - chemistry | Phosphatidylcholines - analysis | Lysophosphatidylcholines - analysis | Phosphatidylcholines - blood | Blood Platelets - chemistry | Fatty Acids - analysis | Ceramides - analysis | Lysophospholipids - blood | Plasmalogens - analysis | Blood Cells - chemistry | Phosphatidylserines - analysis | Sphingomyelins - analysis | Phosphatidylglycerols - analysis | Cholesterol Esters - analysis | Monocytes - chemistry | Granulocytes - chemistry | Sphingomyelins - blood | Phosphatidylglycerols - blood | Lipids - analysis | Mass Spectrometry - methods | Phosphatidylserines - blood | Unsaturated fatty acids | Chemical properties | Mass spectrometry | Analysis
Journal Article
Circulation Research, ISSN 0009-7330, 07/2015, Volume 117, Issue 4, pp. 376 - 387
Journal Article
Lipids in Health and Disease, ISSN 1476-511X, 2013, Volume 12, Issue 1, pp. 20 - 20
Journal Article
BBA - Molecular and Cell Biology of Lipids, ISSN 1388-1981, 05/2016, Volume 1861, Issue 5, pp. 449 - 461
PLA2G6 or GVIA calcium-independent PLA2 (iPLA2β) is identified as one of the NAFLD modifier genes in humans, and thought to be a target for NAFLD therapy.... 
Lysophospholipids | Fatty liver | Insulin resistance | Phospholipid fatty-acyl remodeling | Lipid metabolism | Morbid obesity | PLA2G6 | CALCIUM-INDEPENDENT GROUP | PPAR-ALPHA | BIOCHEMISTRY & MOLECULAR BIOLOGY | EXPRESS GROUP | MASS-SPECTROMETRY | PREVENTS OBESITY | CELL BIOLOGY | PANCREATIC-ISLETS | BIOPHYSICS | INSULIN-RESISTANCE | HIGH-THROUGHPUT QUANTIFICATION | GROUP IVA | ARACHIDONIC-ACID INCORPORATION | Non-alcoholic Fatty Liver Disease - pathology | Liver - pathology | Group VI Phospholipases A2 - deficiency | Liver - enzymology | Arachidonic Acid - blood | Phosphatidylethanolamines - blood | Male | Insulin - blood | PPAR gamma - metabolism | Cholesterol Esters - blood | Obesity - blood | Obesity - genetics | Non-alcoholic Fatty Liver Disease - blood | Group VI Phospholipases A2 - genetics | Non-alcoholic Fatty Liver Disease - enzymology | Phospholipids - blood | Fatty Acids - blood | Disease Models, Animal | PPAR gamma - genetics | Phosphatidylcholines - blood | Non-alcoholic Fatty Liver Disease - genetics | Oxidation-Reduction | Mice, Inbred C57BL | Gene Expression Regulation | Insulin Resistance | Genotype | Lysophospholipids - blood | Mice, Knockout | Obesity - pathology | Phenotype | Animals | Docosahexaenoic Acids - blood | Obesity - prevention & control | Non-alcoholic Fatty Liver Disease - prevention & control | Triglycerides - blood | Obesity - enzymology | Blood Glucose - metabolism | Apoptosis
Journal Article
Trends in Molecular Medicine, ISSN 1471-4914, 2015, Volume 21, Issue 6, pp. 354 - 363
Highlights • S1P is a pleiotropic signaling molecule that regulates BBB permeability. • Fingolimod targets S1P receptors and may have therapeutic potential in... 
Pathology | blood–brain barrier | sphingosine 1-phosphate | neuroinflammation | astrocyte | fingolimod | multiple sclerosis | Neuroinflammation | Multiple sclerosis | Astrocyte | Blood-brain barrier | Fingolimod | Sphingosine 1-phosphate | blood-brain barrier | MEDICINE, RESEARCH & EXPERIMENTAL | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | RELAPSING MULTIPLE-SCLEROSIS | ORAL FINGOLIMOD | BIOCHEMISTRY & MOLECULAR BIOLOGY | ASTROCYTE-ENDOTHELIAL INTERACTIONS | PROTEIN-COUPLED RECEPTORS | FINGOLIMOD FTY720 | CELL BIOLOGY | VE-CADHERIN | CENTRAL-NERVOUS-SYSTEM | PLACEBO-CONTROLLED TRIAL | SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 | Fingolimod Hydrochloride - pharmacology | Lysophospholipids - metabolism | Humans | Astrocytes - pathology | Capillary Permeability - drug effects | Lysophospholipids - immunology | Astrocytes - immunology | Sphingosine - metabolism | Receptors, Lysosphingolipid - metabolism | Astrocytes - drug effects | Blood-Brain Barrier - immunology | Endothelial Cells - metabolism | Sphingosine - immunology | Blood-Brain Barrier - drug effects | Blood-Brain Barrier - metabolism | Endothelial Cells - immunology | Blood-Brain Barrier - pathology | Receptors, Lysosphingolipid - immunology | Sphingosine - analogs & derivatives | Animals | Signal Transduction - drug effects | Multiple Sclerosis - immunology | Multiple Sclerosis - pathology | Endothelial Cells - pathology | Immunologic Factors - pharmacology | Astrocytes - metabolism | Endothelial Cells - drug effects | Multiple Sclerosis - drug therapy | Phosphates | Sphingosine | Permeability | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, pp. e0168302 - e0168302
Background and Objectives Atherosclerotic changes of arteries are the leading cause for deaths in cardiovascular disease and greatly impair patient's quality... 
HDL | PLASMA | SERUM SPHINGOSINE-1-PHOSPHATE | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | HUMAN PLATELETS | RELEASE | SEPSIS | LYMPHOCYTE EGRESS | CORONARY-ARTERY-DISEASE | SPHINGOSINE 1-PHOSPHATE | Prognosis | Area Under Curve | Lipoproteins, HDL - blood | Humans | Middle Aged | Male | Case-Control Studies | Young Adult | Blood Coagulation | Peripheral Arterial Disease - blood | Aged, 80 and over | Adult | Female | Signal Transduction | Cholesterol, HDL - metabolism | Risk Factors | Lysophospholipids - blood | Atherosclerosis - blood | Regression Analysis | Sphingosine - analogs & derivatives | Sphingosine - blood | ROC Curve | Aged | Carotid Stenosis - blood | Cohort Studies | Care and treatment | Usage | Magnetic resonance imaging | Cholesterol, HDL | Atherosclerosis | Research | Cardiovascular diseases | Peripheral vascular diseases | Heart attack | Risk factors | Phosphates | Heart | Arrhythmia | Medical services | Stenosis | Cardiovascular disease | Blood | Arteries | Sphingosine 1-phosphate | Ethics | Toxicology | Ultrasonic imaging | Vascular diseases | Blood platelets | Surgery | Chronic obstructive pulmonary disease | Pretreatment | Lipoproteins (high density) | Hypertension | Cardiovascular system | Kidneys | Blood & organ donations | Diabetes mellitus | Lung diseases | Mass spectroscopy | Risk analysis | Patients | Cholesterol | Blood flow | Quality of life | Medicine | Signaling | Arteriosclerosis | Coronary vessels | Obstructive lung disease | Conditioned stimulus | Sepsis | Mass spectrometry | Smoking | Kidney transplantation | Index Medicus
Journal Article
Journal of Cerebral Blood Flow & Metabolism, ISSN 0271-678X, 3/2013, Volume 33, Issue 3, pp. 381 - 388
At the blood–brain and blood–spinal cord barriers, P-glycoprotein, an ATP-driven drug efflux pump, is a major obstacle to central nervous system (CNS)... 
blood-brain barrier | physiology | endothelium | confocal microscopy | pharmacology | CELLS | DRUG-DELIVERY | TRAFFICKING | EXPORT | NEUROSCIENCES | RESISTANCE-ASSOCIATED PROTEINS | TRANSPORT | SPHINGOSINE-1-PHOSPHATE | ENDOCRINOLOGY & METABOLISM | MICE | HEMATOLOGY | EXPRESSION | Tumor Necrosis Factor-alpha - metabolism | Lysophospholipids - metabolism | Receptors, Lysosphingolipid - antagonists & inhibitors | Spinal Cord - metabolism | Tumor Necrosis Factor-alpha - genetics | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Biological Transport, Active - physiology | Receptors, Lysosphingolipid - genetics | Multidrug Resistance-Associated Proteins - genetics | Sphingosine - metabolism | Receptors, Lysosphingolipid - metabolism | Capillaries - metabolism | Immunosuppressive Agents - pharmacology | Propylene Glycols - pharmacology | Endothelial Cells - metabolism | Biological Transport, Active - drug effects | Fingolimod Hydrochloride | Sphingolipids - metabolism | Nerve Tissue Proteins - genetics | Blood-Brain Barrier - metabolism | Mice, Knockout | Nerve Tissue Proteins - metabolism | Sphingosine - pharmacology | Lysophospholipids - genetics | Sphingosine - analogs & derivatives | Animals | Sphingolipids - genetics | Signal Transduction - drug effects | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Sphingosine - genetics | Signal Transduction - physiology | Mice | Multidrug Resistance-Associated Proteins - metabolism | Index Medicus | Drugs | Brain | Spinal cord | MRP protein | Central nervous system | Sphingolipids | Endothelial cells | Sphingosine 1-phosphate | Blood-brain barrier | Metabolites | Cerebral blood flow | FTY720 | Capillaries | P-Glycoprotein | Protein transport | Tumor necrosis factor- alpha | blood–brain barrier | Original
Journal Article
Science, ISSN 0036-8075, 4/2007, Volume 316, Issue 5822, pp. 295 - 298
Journal Article
Gastroenterology, ISSN 0016-5085, 2010, Volume 139, Issue 3, pp. 1008 - 1018.e1
Journal Article